Your Cart

Call us: +1 (870) 533-5581

Free shipping on all orders over $100 (US) and $300 (International)

Share

Telmisartan, 2400mg (40mg/capsule)

$49.95

508 in stock

BUY 3 GET 10% OFF
This item is selling fast!

Free shipping on all orders over $100 (US) and $300 (International)

Guaranteed Safe Checkout:

“SwissChems Payment Methods

Properties

  • Chemical Formula: C33H30N4O2
  • Molecular Mass: 514.617
  • Synonyms: Telmisartan, 144701-48-4, Micardis, Pritor, BIBR 277
  • Molar Mass: 514.6
  • CAS Number: 144701-48-4
  • PubChem: 65999
  • Total Amount of the Active Ingredient: 40 mg/60 capsules
  • Shelf Life: 36 months

 

Description 

  • Telmisartan is an angiotensin II receptor blocker (ARB) that blocks the actions of angiotensin II, a hormone that causes blood vessels to constrict and increases blood pressure. Its action leads to the relaxation of blood vessels, reduction in blood pressure, and improvement of blood flow to the heart and other organs.In addition to its antihypertensive effects, Telmisartan has been studied for its potential effects in other areas such as cardiovascular disease, diabetes, and cancer with promising results.

It has been shown to reduce the incidence of cardiovascular events such as heart attack and stroke in high-risk patients and improve insulin sensitivity and reduce blood glucose levels in patients with type 2 diabetes.

Telmisartan is still being investigated for its potential to inhibit the growth of certain types of cancer cells, including breast, lung, and prostate cancer, prevent diabetic nephropathy (kidney disease), and improve lipid profiles.

Product Quality

All of our products are lab tested and the results are occasionally published on the website.

You can have the product you bought from us tested at any HPLC-licensed testing facility and if the results are negative, we will refund the following:

  • Cost of HPLC test
  • Total amount of the order + shipping fee

All of our products are lab tested and the results are periodically published on the website.

Peer-Reviewed Studies 

Yusuf, S., Diener, H. C., Sacco, R. L., Cotton, D., Ôunpuu, S., Lawton, W. A., … & Yoon, B. W. (2008)

New England Journal of Medicine, 359(12), 1225-1237.

Galzerano, D., Capogrosso, C., Di Michele, S., Galzerano, A., Paparello, P., Lama, D., & Gaudio, C. (2010)

Vascular health and risk management, 6, 113.